TY - JOUR
T1 - S100A8/A9 regulates CD11b expression and neutrophil recruitment during chronic tuberculosis
AU - Scott, Ninecia R.
AU - Swanson, Rosemary V.
AU - Al-Hammadi, Noor
AU - Domingo-Gonzalez, Racquel
AU - Rangel-Moreno, Javier
AU - Kriel, Belinda A.
AU - Bucsan, Allison N.
AU - Das, Shibali
AU - Ahmed, Mushtaq
AU - Mehra, Smriti
AU - Treerat, Puthayalai
AU - Cruz-Lagunas, Alfredo
AU - Jimenez-Alvarez, Luis
AU - Muñoz-Torrico, Marcela
AU - Bobadilla-Lozoya, Karen
AU - Vogl, Thomas
AU - Walzl, Gerhard
AU - Du Plessis, Nelita
AU - Kaushal, Deepak
AU - Scriba, Thomas J.
AU - Zúñiga, Joaquín
AU - Khader, Shabaana A.
N1 - Publisher Copyright:
© 2020, American Society for Clinical Investigation.
PY - 2020/6/1
Y1 - 2020/6/1
N2 - Neutrophil accumulation is associated with lung pathology during active tuberculosis (ATB). However, the molecular mechanism or mechanisms by which neutrophils accumulate in the lung and contribute to TB immunopathology are not fully delineated. Using the well-established mouse model of TB, our new data provide evidence that the alarmin S100A8/A9 mediates neutrophil accumulation during progression to chronic TB. Depletion of neutrophils or S100A8/A9 deficiency resulted in improved Mycobacterium tuberculosis (Mtb) control during chronic but not acute TB. Mechanistically, we demonstrate that, following Mtb infection, S100A8/A9 expression is required for upregulation of the integrin molecule CD11b specifically on neutrophils, mediating their accumulation during chronic TB disease. These findings are further substantiated by increased expression of S100A8 and S100A9 mRNA in whole blood in human TB progressors when compared with nonprogressors and rapidly decreased S100A8/A9 protein levels in the serum upon TB treatment. Furthermore, we demonstrate that S100A8/A9 serum levels along with chemokines are useful in distinguishing between ATB and asymptomatic Mtb-infected latent individuals. Thus, our results support targeting S100A8/A9 pathways as host-directed therapy for TB.
AB - Neutrophil accumulation is associated with lung pathology during active tuberculosis (ATB). However, the molecular mechanism or mechanisms by which neutrophils accumulate in the lung and contribute to TB immunopathology are not fully delineated. Using the well-established mouse model of TB, our new data provide evidence that the alarmin S100A8/A9 mediates neutrophil accumulation during progression to chronic TB. Depletion of neutrophils or S100A8/A9 deficiency resulted in improved Mycobacterium tuberculosis (Mtb) control during chronic but not acute TB. Mechanistically, we demonstrate that, following Mtb infection, S100A8/A9 expression is required for upregulation of the integrin molecule CD11b specifically on neutrophils, mediating their accumulation during chronic TB disease. These findings are further substantiated by increased expression of S100A8 and S100A9 mRNA in whole blood in human TB progressors when compared with nonprogressors and rapidly decreased S100A8/A9 protein levels in the serum upon TB treatment. Furthermore, we demonstrate that S100A8/A9 serum levels along with chemokines are useful in distinguishing between ATB and asymptomatic Mtb-infected latent individuals. Thus, our results support targeting S100A8/A9 pathways as host-directed therapy for TB.
UR - http://www.scopus.com/inward/record.url?scp=85085715212&partnerID=8YFLogxK
U2 - 10.1172/JCI130546
DO - 10.1172/JCI130546
M3 - Article
C2 - 32134742
AN - SCOPUS:85085715212
SN - 0021-9738
VL - 130
SP - 3098
EP - 3112
JO - Journal of Clinical Investigation
JF - Journal of Clinical Investigation
IS - 6
ER -